Clinical Trial: A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Brief Summary: Purpose: This study will assess the safety and efficacy of Endostar combined with chemotherapy in osteosarcoma patients.
Detailed Summary:
Sponsor: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Current Primary Outcome: Progression Free Survival [ Time Frame: 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Limb Salvage Rate [ Time Frame: end of the first cycle ]
- Overall Survival [ Time Frame: 5 years ]
- Clinical Response Rate [ Time Frame: end of the first cycle ]
- Clinical Benefit Response [ Time Frame: end of the first cycle ]
- Quality of Life [ Time Frame: after 4 cycles ]
Original Secondary Outcome: Same as current
Information By: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Dates:
Date Received: October 25, 2009
Date Started: February 2009
Date Completion: December 2014
Last Updated: August 31, 2014
Last Verified: August 2014
